In the SST22+/- pancreatic cancer mouse model, sustained PI3K-AKT signaling activation could cross with KRASG12D mice and further accelerate PDAC progression (Chalabi-Dchar et al., 2015). The gene discussed is AKT1; the disease is pancreatic neoplasm.